Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Elio Adib MD

Elio Adib MD

Department of Pulmonary Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Dr. Elio Adib is a resident in internal medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He received his medical degree from the American University of Beirut, Faculty of Medicine, in Lebanon, following which he moved to the United States and pursued a postdoctoral fellowship at the Brigham and Women’s Hospital/Dana-Farber Cancer Institute.

Dr. Adib’s interests are focused on genomics and epigenetics of genitourinary tumors, and he has published more than 15 peer-reviewed journal articles.

Recent Contributions to PracticeUpdate:

  1. MTAP Deficiency Creates an Exploitable Target for Antifolate Therapy in 9p21-Loss Cancers
  2. Outcomes With Pembrolizumab in Patients Previously Treated With Chemoradiation or Total Cystectomy

Recently Updated